Stem cell therapy for chronic heart failure. Lessons from a 15-year experience

Comptes Rendus - Biologies

Volumn 334, Issue 7, 2011, Pages 489-496

  Menasché, Philippe ^a  

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

Heart failure; Myocardial infarction; Regenerative medicine; Stem cells

Indexed keywords

APOPTOSIS; BIOTECHNOLOGY; CARDIOVASCULAR DISEASE; CYTOLOGY; DISEASE TREATMENT; MEDICINE; TECHNOLOGICAL DEVELOPMENT;

ANGIOGENESIS; APOPTOSIS; CELL PROTECTION; CELL TYPE; HEART FAILURE; HEART MUSCLE CELL; REVIEW; STEM CELL TRANSPLANTATION;

EID: 79960843852     PISSN: 16310691     EISSN: 17683238     Source Type: Journal    
DOI: 10.1016/j.crvi.2011.03.006     Document Type: Short Survey

References (68)

1. D. Lloyd-Jones, R. Adams, and M. Carnethon Heart disease and stroke statistics - 2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee Circulation 119 2009 e21 e181
2. K.R. Vrijsen, S.A. Chamuleau, W.A. Noort, P.A. Doevendans, and J.P. Sluijter Stem cell therapy for end-stage heart failure: indispensable role for the cell? Curr. Opin. Organ Transplant 14 2009 560 565 (Review)
3. Ph. Menasché, O. Alfieri, S. Janssens, W. McKenna, H. Reichenspurner, L. Trinquart, J.T. Vilquin, J.P. Marolleau, B. Seymour, J. Larghero, S. Lake, G. Chatellier, S. Solomon, M. Desnos, and A.A. Hagge The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) Trial. First randomized placebo-controlled study of myoblast transplantation Circulation 117 2008 1189 1200 (Pubitemid 351552018)
4. C.E. Veltman, O.I. Soliman, M.L. Geleijnse, W.B. Vletter, P.C. Smits, F.J. ten Cate, L.J. Jordaens, A.H. Balk, P.W. Serruys, E. Boersma, R.T. van Domburg, and W.J. van der Giessen Four-year follow-up of treatment with intramyocardial skeletal myoblasts injection in patients with ischaemic cardiomyopathy Eur. Heart J. 29 2008 1386 1396 (Pubitemid 351806492)
5. N. Dib, J. Dinsmore, Z. Lababidi, B. White, S. Moravec, A. Campbell, A. Rosenbaum, K. Seyedmadani, W.A. Jaber, C.S. Rizenhour, and E. Diethrich One-year follow-up of feasibility and safety of the first U.S., randomized, controlled study using 3-dimensional guided catheter-based delivery of autologous skeletal myoblasts for ischemic cardiomyopathy (CAuSMIC study) JACC Cardiovasc. Interv. 2 2009 9 16
6. P. Menasche Cell-based therapy for heart disease: a clinically oriented perspective Mol. Ther. 17 2009 758 766
7. B.E. Strauer, M. Brehm, T. Zeus, T. Bartsch, C. Schannwell, C. Antke, R.V. Sorg, G. Kögler, P. Wernet, H.W. Müller, and M. Köstering Regeneration of human infarcted heart muscle by intracoronary autologous bone marrow cell transplantation in chronic coronary artery disease: the IACT Study J. Am. Coll. Cardiol. 46 2005 1651 1658 (Pubitemid 41531618)
8. U. Fischer-Rasokat, B. Assmus, F.H. Seeger, H. Honold, D. Leistner, S. Fichtlscherer, V. Schächinger, T. Tonn, H. Martin, S. Dimmeler, and A.M. Zeiher A pilot trial to assess potential effects of selective intra-coronary bone marrow-derived progenitor cell infusion in patients with nonischemic dilated cardiomyopathy: Final 1-year results of the TOPCARE-DCM trial Circ. Heart Fail. 2 2009 417 423
9. Q. Zhao, Y. Sun, L. Xia, A. Chen, and Z. Wang Randomized study of mononuclear bone marrow cell transplantation in patients with coronary surgery Ann. Thorac. Surg. 86 2008 1833 1840
10. A.R. Akar, S. Durdu, M. Arat, M. Kilickap, N.O. Kucuk, O. Arslan, I. Kuzu, and U. Ozyurda Five-year follow-up after transepicardial implantation of autologous bone marrow mononuclear cells to ungraftable coronary territories for patients with ischaemic cardiomyopathy Eur. J. Cardiothorac. Surg. 36 2009 633 643
11. C. Stamm, H.D. Kleine, Y.H. Choi, S. Dunkelmann, J.A. Lauffs, B. Lorenzen, A. David, A. Liebold, C. Nienaber, D. Zurakowski, M. Freund, and G. Steinhoff Intramyocardial delivery of CD133+ bone marrow cells and coronary artery bypass grafting for chronic ischemic heart disease: safety and efficacy studies J. Thorac. Cardiovasc. Surg. 133 2007 717 725
12. H. Cheng, V. Chen, C. Kim, and M. Mercola Electrophysiological challenges of cell-based myocardial repair Circulation 120 2009 2496 2508
13. M. Perez-Ilzarbe, O. Agbulut, B. Pelacho, C. Ciorba, E. San Jose-Eneriz, M. Desnos, A.A. Hagge, P. Aranda, E.J. Andreu, P. Menasché, and F. Prósper Characterization of the paracrine effects of human skeletal myoblasts transplanted in infarcted myocardium Eur. J. Heart Fail. 10 2008 1065 1072
14. T. Kinnaird, E. Stabile, M.S. Burnett, C.W. Lee, S. Barr, S. Fuchs, and S.E. Epstein Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms Circ. Res. 94 2004 678 685 (Pubitemid 38387752)
15. H.J. Cho, N. Lee, J.Y. Lee, Y.J. Choi, M. Ii, A. Wecker, J.O. Jeong, C. Curry, G. Qin, and Y.S. Yoon Role of host tissues for sustained humoral effects after endothelial progenitor cell transplantation into the ischemic heart J. Exp. Med. 204 2007 3257 3269
16. J.M. Vieira, and P.R. Riley Epicardium-derived cells: a new source of regenerative capacity Heart 97 2011 15 19
17. F. Di Meglio, C. Castaldo, D. Nurzynska, V. Romano, R. Miraglia, C. Bancone, G. Langella, C. Vosa, and S. Montagnani Epithelial-mesenchymal transition of epicardial mesothelium is a source of cardiac CD117-positive stem cells in adult human heart J. Mol. Cell. Cardiol. 49 2010 719 727
18. L. Timmers, S.K. Lim, F. Arslan, J.S. Armstrong, I.E. Hoefer, P.A. Doevendans, J.J. Piek, R.M. El Oakley, A. Choo, C.N. Lee, G. Pasterkamp, and D.P. de Kleijn Reduction of myocardial infarct size by human mesenchymal stem cell conditioned medium Stem. Cell. Res. 1 2007 129 137
19. H. Reinecke, V. Poppa, and C.E. Murry Skeletal muscle stem cells do not transdifferentiate into cardiomyocytes after cardiac grafting Mol. Cell. Cardiol. 34 2002 241 249 (Pubitemid 35222833)
20. J.A. Scherschel, M.H. Soonpaa, E.F. Srour, L.J. Field, and M. Rubart Adult bone marrow-derived cells do not acquire functional attributes of cardiomyocytes when transplanted into peri-infarct myocardium Mol. Ther. 16 2008 1129 1137 (Pubitemid 351737079)
21. S. Bollini, N. Smart, and P.R. Riley Resident cardiac progenitor cells: at the heart of regeneration Mol. Cell. Cardiol. 50 2011 296 303
22. J. Pouly, P. Bruneval, C. Mandet, S. Proksch, S. Peyrard, C. Amrein, V. Bousseaux, R. Guillemain, A. Deloche, J.N. Fabiani, and P. Menasché Cardiac stem cells in the real world Thorac. Cardiovasc. Surg. 135 2008 673 678 (Pubitemid 351343809)
23. R. Mishra, K. Vijayan, E.J. Colletti, D.A. Harrington, T.S. Matthiesen, D. Simpson, S.K. Goh, B.L. Walker, G. Almeida-Porada, D. Wang, C.L. Backer, S.C. Dudley Jr., L.E. Wold, and S. Kaushal Characterization and functionality of cardiac progenitor cells in congenital heart patients Circulation 123 2011 364 373
24. E.R. Porrello, A.I. Mahmoud, E. Simpson, J.A. Hill, J.A. Richardson, E.N. Olson, and H.A. Sadek Transient regenerative potential of the neonatal mouse heart Science 331 2011 1078 1080
25. I. Chimenti, R.R. Smith, T.S. Li, G. Gerstenblith, E. Messina, A. Giacomello, and E. Marbán Relative roles of direct regeneration versus paracrine effects of human cardiosphere-derived cells transplanted into infarcted mice Circ. Res. 106 2010 971 980
26. G. Blin, D. Nury, S. Stefanovic, T. Neri, O. Guillevic, B. Brinon, V. Bellamy, C. Rücker-Martin, P. Barbry, A. Bel, P. Bruneval, C. Cowan, J. Pouly, S. Mitalipov, E. Gouadon, P. Binder, A. Hagge, M. Desnos, J.F. Renaud, P. Menasché, and M. Pucéat A purified population of multipotent cardiovascular progenitors derived from primate pluripotent stem cells engrafts in postmyocardial infarcted nonhuman primates J. Clin. Invest. 120 2010 1125 1139
27. O. Caspi, I. Huber, I. Kehat, M. Habib, G. Arbel, A. Gepstein, L. Yankelson, D. Aronson, R. Beyar, and L. Gepstein Transplantation of human embryonic stem cell-derived cardiomyocytes improves myocardial performance in infarcted rat hearts J. Am. Coll. Cardiol. 50 2007 1884 1893 (Pubitemid 350007960)
28. R.J. Swijnenburg, S. Schrepfer, J.A. Govaert, F. Cao, K. Ransohoff, A.Y. Sheikh, M. Haddad, A.J. Connolly, M.M. Davis, R.C. Robbins, and J.C. Wu Immunosuppressive therapy mitigates immunological rejection of human embryonic stem cell xenografts Proc. Natl. Acad. Sci. U S A 105 2008 12991 12996
29. B. Keymeulen, E. Vandemeulebroucke, A.G. Ziegler, C. Mathieu, L. Kaufman, G. Hale, F. Gorus, M. Goldman, M. Walter, S. Candon, L. Schandene, L. Crenier, C. De Block, J.M. Seigneurin, P. De Pauw, D. Pierard, I. Weets, P. Rebello, P. Bird, E. Berrie, M. Frewin, H. Waldmann, J.F. Bach, D. Pipeleers, and L. Chatenoud Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes N Engl J Med 352 2005 2598 2608 (Pubitemid 41007846)
30. J.I. Pearl, A.S. Lee, D.B. Leveson-Gower, N. Sun, Z. Ghosh, F. Lan, J. Ransohoff, R.S. Negrin, M.M. Davis, and J.C. Wu Short-term immunosuppression promotes engraftment of embryonic and induced pluripotent stem cells Cell Stem Cell 8 2011 309 317
31. H. Gai, E.L. Leung, P.D. Costantino, J.R. Aguila, D.M. Nguyen, L.M. Fink, D.C. Ward, and Y. Ma Generation and characterization of functional cardiomyocytes using induced pluripotent stem cells derived from human fibroblasts Cell. Biol. Int. 33 2009 1184 1193
32. M.F. Pera The dark side of induced pluripotency Nature 471 2011 46 47
33. K.H. Narsinh, N. Sun, V. Sanchez-Freire, A.S. Lee, P. Almeida, S. Hu, T. Jan, K.D. Wilson, D. Leong, J. Rosenberg, M. Yao, R.C. Robbins, J.C. Wu, Single cell transcriptional profiling reveals heterogeneity of human induced pluripotent stem cells. J. Clin. Invest. 2011 Feb 7. pii: 44635. doi: 10.1172/JCI44635.
34. A. Behfar, S. Yamada, R. Crespo-Diaz, J.J. Nesbitt, L.A. Rowe, C. Perez-Terzic, V. Gaussin, C. Homsy, J. Bartunek, and A. Terzic Guided cardiopoiesis enhances therapeutic benefit of bone marrow human mesenchymal stem cells in chronic myocardial infarction J. Am. Coll. Cardiol. 56 2010 721 734
35. L. Sensebé, P. Bourin, and K. Tarte Good manufacturing practices production of mesenchymal stem/stromal cells Hum. Gene Ther. 22 2011 19 26
36. X.P. Huang, Z. Sun, Y. Miyagi, H. McDonald Kinkaid, L. Zhang, and R.D. Weisel R.K. L, Differentiation of allogeneic mesenchymal stem cells induces immunogenicity and limits their long-term benefits for myocardial repair Circulation 122 2010 2419 2429
37. J.A. Efe, S. Hilcove, J. Kim, H. Zhou, K. Ouyang, G. Wang, J. Chen, and S. Ding Conversion of mouse fibroblasts into cardiomyocytes using a direct reprogramming strategy Nat. Cell. Biol. 2011 (Jan 30. doi:10.1038/ncb2164)
38. J. Müller-Ehmsen, B. Krausgrill, V. Burst, K. Schenk, U.C. Neisen, J.W. Fries, B.K. Fleischmann, J. Hescheler, and R.H. Schwinger Effective engraftment but poor mid-term persistence of mononuclear and mesenchymal bone marrow cells in acute and chronic rat myocardial infarction Mol. Cell. Cardiol. 41 2006 876 884 (Pubitemid 44635568)
39. T.E. Robey, M.K. Saiget, H. Reinecke, and C.E. Murry Systems approaches to preventing transplanted cell death in cardiac repair Mol. Cell. Cardiol. 45 2008 567 581
40. J. Westrich, P. Yaeger, C. He, J. Stewart, R. Chen, G. Seleznik, S. Larson, B. Wentworth, M. O'Callaghan, S. Wadsworth, G. Akita, and G. Molnar Factors affecting residence time of mesenchymal stromal cells (MSC) injected into the myocardium Cell Transplant 19 2010 937 948
41. D. Sarkar, J.A. Ankrum, G.S. Teo, C.V. Carman, and J.M. Karp Cellular and extracellular programming of cell fate through engineered intracrine-, paracrine-, and endocrine-like mechanisms Biomaterials 32 2011 3053 3061
42. K Cheng, T.S. Li, K. Malliaras, D.R. Davis, Y. Zhang, and E. Marbán Cellular and extracellular programming of cell fate through engineered intracrine-, paracrine-, and endocrine-like mechanisms Biomaterials 32 106 2010 1570 1581
43. S.H. Li, T.Y. Lai, Z. Sun, M. Han, E. Moriyama, B. Wilson, S. Fazel, R.D. Weisel, T. Yau, J.C. Wu, and R.K. Li Tracking cardiac engraftment and distribution of implanted bone marrow cells: Comparing intra-aortic, intravenous, and intramyocardial delivery Thorac. Cardiovasc. Surg. 137 2009 1225 1233
44. H Song, H.J. Hwang, W. Chan, B.W. Song, M.J. Cha, I.K. Kim, S. Lim, E.J. Choi, O. Ham, C.Y. Lee, J.H. Park, S.Y. Lee, E. Choi, C. Lee, M. Lee, M.H. Lee, S.H. Kim, Y. Jang, and K.C. Hwang Cardiomyocytes from phorbol myristate acetate-activated mesenchymal stem cells restore electromechanical function in infarcted rat hearts Proc. Natl. Acad. Sci. U S A. 108 2011 296 301
45. P.L. Richard, C. Gosselin, T. Laliberté, M. Paradis, M. Goulet, J.P. Tremblay, and D. Skuk A first semimanual device for clinical intramuscular repetitive cell injections Cell Transplant 19 2010 67 78
46. T.P. Martens, A.F. Godier, J.J. Parks, L.Q. Wan, M.S. Koeckert, G.M. Eng, B.L. Hudson, W. Sherman, and G. Vunjak-Novakovic Percutaneous cell delivery into the heart using hydrogels polymerizing in situ Cell. Transplant. 18 2009 297 304
47. J. Yang, M. Yamato, K. Nishida, T. Ohki, M. Kanzaki, H. Sekine, T. Shimizu, and T. Okano Cell delivery in regenerative medicine: the cell sheet engineering approach J Control Release 116 2006 193 203 (Pubitemid 44854275)
48. I.A. Memon, Y. Sawa, N. Fukushima, G. Matsumiya, S. Miyagawa, S. Taketani, S.K. Sakakida, H. Kondoh, A.N. Aleshin, T. Shimizu, T. Okano, and H. Matsuda Repair of impaired myocardium by means of implantation of engineered autologous myoblast sheets Thorac. Cardiovasc. Surg. 130 2005 1333 1341 (Pubitemid 41543202)
49. S. Miyagawa, G. Matsumiya, T. Funatsu, M. Yoshitatsu, N. Sekiya, S. Fukui, T. Hoashi, M. Hori, H. Yoshikawa, Y. Kanakura, J. Ishikawa, K. Aozasa, N. Kawaguchi, N. Matsuura, A. Myoui, A. Matsuyama, S. Ezoe, H. Iida, H. Matsuda, and Y. Sawa Combined autologous cellular cardiomyoplasty using skeletal myoblasts and bone marrow cells for human ischemic cardiomyopathy with left ventricular assist system implantation: report of a case Surg. Today 39 2009 133 136
50. H. Hamdi, A. Furuta, V. Bellamy, A. Bel, E. Puymirat, S. Peyrard, O. Agbulut, and P. Menasché Cell delivery: intramyocardial injections or epicardial deposition? A head-to-head comparison Ann. Thorac. Surg. 87 2009 1196 1203
51. S. Miyagawa, M. Roth, A. Saito, Y. Sawa, and S. Kostin Tissue-engineered cardiac constructs for cardiac repair Ann. Thorac. Surg. 91 2011 320 329
52. K.R. Stevens, K.L. Kreutziger, S.K. Dupras, F.S. Korte, M. Regnier, V. Muskheli, M.B. Nourse, K. Bendixen, H. Reinecke, and C.E. Murry Physiological function and transplantation of scaffold-free and vascularized human cardiac muscle tissue Proc. Natl. Acad. Sci. U S A. 106 2009 16568 16573
53. E.M. Winter, A.A.M. van Oorschot, B. Hogers, L.M. van der Graaf, P.A. Doevendans, R.E. Poelmann, D.E. Atsma, A.C. Gittenberger-de Groot, and M.J. Goumans A new direction for cardiac regeneration: Application of synergistically acting epicardium-derived cells and cardiomyocyte progenitor cells Circ. Heart Fail. 2 2009 643 653
54. L. Zakharova, D. Mastroeni, N. Mutlu, M. Molina, S. Goldman, E. Diethrich, and M.A. Gaballa Transplantation of cardiac progenitor cell sheet onto infarcted heart promotes cardiogenesis and improves function Cardiovasc. Res. 87 2010 40 49
55. K. Matsuura, A. Honda, T. Nagai, N. Fukushima, K. Iwanaga, M. Tokunaga, T. Shimizu, T. Okano, H. Kasanuki, N. Hagiwara, and I. Komuro Transplantation of cardiac progenitor cells ameliorates cardiac dysfunction after myocardial infarction in mice J. Clin. Invest. 119 2009 2204 2217
56. E. Puymirat, R. Geha, A. Tomescot, V. Bellamy, J. Larghero, L. Trinquart, P. Bruneval, M. Desnos, A. Hagge, M. Pucéat, and P. Menasché Can mesenchymal stem cells induce tolerance to cotransplanted human embryonic stem cells? Mol. Ther. 17 2009 176 182
57. B.A. Blakeney, A. Tambralli, J.M. Anderson, A. Andukuri, D.J. Lim, D.R. Dean, and H.W. Jun Cell infiltration and growth in a low density, uncompressed three-dimensional electrospun nanofibrous scaffold Biomaterials 32 2011 1583 1590
58. G.Y. Chang, X. Xie, and J.C. Wu Overview of stem cells and imaging modalities for cardiovascular diseases J. Nucl. Cardio. 13 2006 554 569 (Pubitemid 44204155)
59. S.S. Yaghoubi, M.C. Jensen, N. Satyamurthy, S. Budhiraja, D. Paik, J. Czernin, and S.S. Gambhir Noninvasive detection of therapeutic cytolytic T cells with 18F-FHBG PET in a patient with glioma Nat. Clin. Pract. Oncol. 6 2009 53 58
60. S.J. Brunskill, C.J. Hyde, C.J. Doree, S.M. Watt, and E. Martin-Rendon Route of delivery and baseline left ventricular ejection fraction, key factors of bone-marrow-derived cell therapy for ischaemic heart disease Eur. J. Heart Fail. 11 2009 887 896
61. C.K Kissel, R. Lehmann, B. Assmus, A. Aicher, J. Honold, U. Fischer- Zeiher Rasokat, C. Heeschen, I. Spyridopoulos, S. Dimmeler, and A.M. Zeiher Selective functional exhaustion of hematopoietic progenitor cells in the bone marrow of patients with postinfarction heart failure J. Am. Coll. Cardiol. 49 2007 2341 2349 (Pubitemid 46891715)
62. W.C. Levy, D. Mozaffarian, D.T. Linker, S.C. Sutradhar, S.D. Anker, A.B. Cropp, I. Anand, A. Maggioni, P. Burton, M.D. Sullivan, B. Pitt, P.A. Poole-Wilson, D.L. Mann, and M. Packer The Seattle Heart Failure Model: prediction of survival in heart failure Circulation 113 2006 1424 1433 (Pubitemid 43739439)
63. T. Tang, J. Wang, J. Yang, X. Kong, F. Zheng, L. Guo, L. Zhang, and Y. Huang Mesenchymal stem cells over-expressing SDF-1 promote angiogenesis and improve heart function in experimental myocardial infarction in rats Eur. J. Cardiothorac. Surg. 36 2009 644 650
64. J.D. Abbott, Y. Huang, D. Liu, R. Hickey, D.S. Krause, and F.J. Giordano Stromal cell-derived factor-1alpha plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury Circulation 110 2004 3300 3305 (Pubitemid 39557491)
65. A. Aicher, C. Heeschen, K. Sasaki, C. Urbich, A.M. Zeiher, and S. Dimmeler Low-energy shock wave for enhancing recruitment of endothelial progenitor cells: a new modality to increase efficacy of cell therapy in chronic hind limb ischemia Circulation 114 2006 2823 2830 (Pubitemid 46018285)
66. T. Mizuno Feasibility of cell transplantation with a left ventricular assist device to improve the success rate of left ventricular assist device removal: the first experiment Interact. Cardiovasc. Thorac. Surg. 12 2011 10 14
67. B.E. Jaski, M.L. Jessup, D.M. Mancini, T.P. Cappola, D.F. Pauly, B. Greenberg, K. Borow, H. Dittrich, K.M. Zsebo, and R.J. Hajjar Calcium Up-Regulation by Percutaneous Administration of Gene Therapy In Cardiac Disease (CUPID) Trial Investigators. Calcium upregulation by percutaneous administration of gene therapy in cardiac disease (CUPID Trial), a first-in-human phase 1/2 clinical trial J. Card. Fail. 15 2009 171 181
68. R.J Frost, and E. van Rooij miRNAs as therapeutic targets in ischemic heart disease J. Cardiovasc. Transl. Res. 3 2010 280 289